The synthesis of atomically precise, structurally well‐defined polyoxometalate (POM)‐stabilized silver clusters with accessible silver surfaces remains a significant challenge. Here, we report an alkynyl‐functionalized silver–POM hybrid nanocluster, [( n ‐Bu) 4 N] 7 [(C 6 H 9 ) 6 (PW 11 O 39 ) 2 Ag 13 ] ( (PW 11 ) 2 ‐Ag 13 ), which comprises of a distinctive homovalent three‐layer {Ag 13 } 13+ cluster. This architecture yields a lower HOMO − LUMO energy gap of 1.93 eV, compared to the precursor [PW 11 O 39 ] 7− (2.74 eV). Structural characterization and theoretical calculations confirm that the lacunary [PW 11 O 39 ] 7− and alkynyl units direct the formation of the atomically precise {Ag 13 } 13+ cluster, preventing undesirable silver aggregation while maintaining exposed silver surfaces that are crucial for catalytic activity. The synergistic redox capabilities of the POM and silver components enhance the redox reactivity of (PW 11 ) 2 ‐Ag 13 , promoting efficient reactive oxygen species (ROS) generation via a Fenton‐like mechanism. Additionally, biological evaluations further reveal that (PW 11 ) 2 ‐Ag 13 exhibits significantly superior antitumor activity than [PW 11 O 39 ] 7− , primarily through ROS‐induced apoptosis facilitated by the active silver cluster sites. These findings highlight the potential of silver cluster‐POM hybrids as promising candidates for anticancer therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: